Łapińska, Z.; Dębiński, M.; Szewczyk, A.; Choromańska, A.; Kulbacka, J.; Saczko, J.
Electrochemotherapy with Calcium Chloride and 17β-Estradiol Modulated Viability and Apoptosis Pathway in Human Ovarian Cancer. Pharmaceutics 2021, 13, 19.
https://doi.org/10.3390/pharmaceutics13010019
AMA Style
Łapińska Z, Dębiński M, Szewczyk A, Choromańska A, Kulbacka J, Saczko J.
Electrochemotherapy with Calcium Chloride and 17β-Estradiol Modulated Viability and Apoptosis Pathway in Human Ovarian Cancer. Pharmaceutics. 2021; 13(1):19.
https://doi.org/10.3390/pharmaceutics13010019
Chicago/Turabian Style
Łapińska, Zofia, Michał Dębiński, Anna Szewczyk, Anna Choromańska, Julita Kulbacka, and Jolanta Saczko.
2021. "Electrochemotherapy with Calcium Chloride and 17β-Estradiol Modulated Viability and Apoptosis Pathway in Human Ovarian Cancer" Pharmaceutics 13, no. 1: 19.
https://doi.org/10.3390/pharmaceutics13010019
APA Style
Łapińska, Z., Dębiński, M., Szewczyk, A., Choromańska, A., Kulbacka, J., & Saczko, J.
(2021). Electrochemotherapy with Calcium Chloride and 17β-Estradiol Modulated Viability and Apoptosis Pathway in Human Ovarian Cancer. Pharmaceutics, 13(1), 19.
https://doi.org/10.3390/pharmaceutics13010019